Overview
Neurotrophin-3 (NT-3) is a neurotrophic growth factor and member of the neurotrophin family, which includes NGF, BDNF, and NT-4. NT-3 supports the survival, development, and differentiation of neurons, particularly proprioceptive sensory neurons and oligodendrocytes. It is studied for potential applications in peripheral neuropathy, spinal cord injury, hearing loss, and neurodegenerative disease.
Mechanism of action
NT-3 binds with highest affinity to the TrkC (NTRK3) receptor tyrosine kinase, triggering autophosphorylation and activation of downstream signaling cascades including PI3K/Akt (promoting neuronal survival), MAPK/ERK (stimulating differentiation and synaptic plasticity), and PLCγ (modulating calcium signaling). NT-3 also binds the pan-neurotrophin receptor p75NTR, which can modulate either survival or apoptosis depending on cellular context. NT-3 promotes myelination by supporting oligodendrocyte precursor maturation.
Dosing protocols
| Purpose | Route | Dosage | Frequency | Notes |
|---|---|---|---|---|
| neuropathy research / preclinical dosing | subcutaneous | 0.5–4 mg/kg | daily or every other day per protocol | |
| central delivery research | intravenous | 0.1–1 mg/kg | per experimental design |
Dosing information is for educational purposes only. Consult a qualified healthcare professional before using any peptide.
Research summary
Preclinical studies demonstrate NT-3's role in rescuing sensory neurons after injury and promoting axonal regeneration. Phase I/II trials in HIV-associated sensory neuropathy showed some benefit. Animal studies support NT-3 in cochlear hair cell survival and hearing preservation after noise damage. Challenges include blood-brain barrier penetration and short plasma half-life, driving research into gene therapy and viral vector delivery of NT-3.
Side effects
Side effects vary by individual. This is not an exhaustive list. Report unusual symptoms to a healthcare professional.
Legal status
NT-3 is not approved for human clinical use and is classified as a research reagent. Clinical trials have used recombinant NT-3 under IND applications.
Where to get it
Verified directory — coming soon
PeptaHub is building a verified supplier directory with third-party testing data, compliance status, and reader ratings.